Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.76 USD | +3.25% | +4.16% | +15.53% |
03:10pm | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
May. 09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.53% | 158M | |
+27.37% | 44.96B | |
+0.06% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.06% | 26.08B | |
-21.08% | 19.03B | |
+6.34% | 12.75B | |
+28.75% | 12.06B | |
-3.60% | 11.75B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Transcript : Achieve Life Sciences, Inc., Q2 2023 Earnings Call, Aug 15, 2023